Summary
Serum triazolam levels were determined in eight geriatric patients (average age 80 years) on Days 1 and 7 of administration of triazolam 0.25 mg once daily, 1 h after a standard breakfast. Triazolam was rapidly absorbed reaching average peak concentrations of 2.0 and 2.04 ng/ml, 1.5 and 1.38 h after administration on Days 1 and 7, respectively. The mean apparent elimination half-life was 1.41 h (range 0.73–4.13 h) on Day 1 and 1.37 h (range 0.69–3.36 h) on Day 7. There was no significant difference between mean serum triazolam concentrations or pharmacokinetic parameters on Days 1 and 7 of the treatment. Serum samples were also assayed for α-hydroxytriazolam, an active metabolite of triazolam, but none could be detected in any of the samples from Days 1 or 7, assay sensitivity 0.09 ng/2 ml serum. The range of half-lives of triazolam in the patients in the present study is in close agreement with that previously reported in elderly subjects. The study provides further evidence of the lack of change in pharmacokinetic parameters on multiple dosing and that drug accumulation did not occur.
Similar content being viewed by others
References
Castleden CM, George CF, Marcer D, Hallett C (1977) Increased sensitivity to nitrazepam in old age. Br Med J 1:10–12
Dolan JW, Vanderwal SJ, Bannister SJ, Snyder LR (1980) One-line liquid-chromatographic analyses for drugs in serum with the Technicon “FAST-LC” system: Performance data for theophylline and for four commonly used anticonvulsants and their metabolites. Clin Chem 26:871–880
Gibaldi M, Perrier D (1975) Drugs and the pharmaceutical sciences, Volume 1, Pharmacokinetics. Marcel Dekker, New York, NY
Greenblatt DJ, Allen MD, Shader RI (1977) Toxicity of high dose flurazepam in the elderly. Clin Pharmacol Ther 21:355–361
Greenblatt DJ, Harmatz JS, Shader RI (1978) Factors influencing diazepam pharmacokinetics: Age, sex and liver disease. Int J Clin Pharmacol 16:177–179
Greenblatt DJ, Shader RJ, Macleod SM, Sellers EN (1978). Clinical pharmacokinetics of chlordiazepoxide: A Review. Clin Pharmacokinet 3:381–394
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Diazepam disposition determinants. Clin Pharmacol Ther 27:301–312
Greenblatt DJ, Divoll M, Harmatz JS, Maclaughlin DS, Shader RI (1981) Kinetics and clinical effects of flurazepam in young and elderly non-insomniac volunteers. Clin Pharmacol Ther 30:475–486
Greenblatt DJ, Divoll M, Abernethy DA, Moschitto LJ, Smith RB, Shader RI (1983) Reduced clearance of triazolam in old age: Relation to antipyrine oxidizing capacity. Br J Clin Pharmacol (in press)
Jochemsen R, Breimer DD (1981). Assay of triazolam in plasma by capillary gas chromatography. J Chromatogr 223:438–444
Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) The effects of age and liver disease in the disposition and elimination in adult man. J Clin Invest 55:347–359
Macleod SM, Giles HG, Bengert B, Liu FF, Sellers EM (1979) Age and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol 19:15–19
Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1981) Triazolam: A review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22:81–110
Sedman AJ, Wagner JG (1976) Cstrip, a Fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65:1006–1010
Shader RI, Greenblatt DJ, Harmatz JS, Franke K, Koch-Weser J (1977) Absorption and disposition of chlordiazepoxide of young and elderly male volunteers. J Clin Pharmacol 17:709–718
Shader RI, Greenblatt DJ (1979) Pharmacokinetics and clinical drug effects in the elderly. Psychopharmacol Bull 15:8–14
Smith RB, Divoll M, Gillespie WR, Greenblatt DJ (1983) Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. J Clin Psychopharmacol (in press)
Weiss M (1981) Residence time and accumulation of drugs in the body. Int J Clin Pharmacol Ther Toxicol 19:82–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dehlin, O., Björnson, G., Börjesson, L. et al. Pharmacokinetics of triazolam in geriatric patients. Eur J Clin Pharmacol 25, 91–94 (1983). https://doi.org/10.1007/BF00544022
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544022